CHAMPIONS ONCOLOGY, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Champions Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q4 2024.
  • Champions Oncology, Inc. Operating Income (Loss) for the quarter ending January 31, 2025 was $4.5M.
  • Champions Oncology, Inc. Operating Income (Loss) for the twelve months ending January 31, 2025 was $6.29M.
  • Champions Oncology, Inc. annual Operating Income (Loss) for 2023 was -$7.36M, a 40% decline from 2022.
  • Champions Oncology, Inc. annual Operating Income (Loss) for 2022 was -$5.26M, a 966% decline from 2021.
  • Champions Oncology, Inc. annual Operating Income (Loss) for 2021 was $607K, a 65.8% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $6.29M $4.5M +$7.08M Nov 1, 2024 Jan 31, 2025 10-Q 2025-03-17
Q3 2024 -$788K $732K +$2.69M Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-16
Q2 2024 -$3.48M $1.33M +$3.88M May 1, 2024 Jul 31, 2024 10-Q 2024-09-13
Q1 2024 -$7.36M -$272K +$2.25M +89.2% Feb 1, 2024 Apr 30, 2024 10-K 2024-07-19
Q4 2023 -$9.61M -$2.58M -$119K -4.84% Nov 1, 2023 Jan 31, 2024 10-Q 2025-03-17
Q3 2023 -$9.49M -$1.96M -$1.96M -28029% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-16
Q2 2023 -$7.52M -$2.55M -$2.27M -799% May 1, 2023 Jul 31, 2023 10-Q 2024-09-13
Q1 2023 -$5.26M -$2.52M -$2.21M -711% Feb 1, 2023 Apr 30, 2023 10-K 2024-07-19
Q4 2022 -$3.05M -$2.46M -$3.29M -396% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-15
Q3 2022 $242K $7K -$256K -97.3% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-13
Q2 2022 $498K -$284K -$109K -62.3% May 1, 2022 Jul 31, 2022 10-Q 2023-09-13
Q1 2022 $607K -$311K +$336K +51.9% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-24
Q4 2021 $271K $830K -$152K -15.5% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-16
Q3 2021 $423K $263K +$256K +3657% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-13
Q2 2021 $167K -$175K -$199K -829% May 1, 2021 Jul 31, 2021 10-Q 2022-09-12
Q1 2021 $366K -$647K +$1.38M +68.1% Feb 1, 2021 Apr 30, 2021 10-K 2022-07-22
Q4 2020 -$1.02M $982K +$549K +127% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 -$1.57M $7K -$284K -97.6% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-13
Q2 2020 -$1.28M $24K +$638K May 1, 2020 Jul 31, 2020 10-Q 2021-09-13
Q1 2020 -$1.92M -$2.03M -$1.92M -1651% Feb 1, 2020 Apr 30, 2020 10-K 2021-07-26
Q4 2019 -$6K $433K +$803K Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-15
Q3 2019 -$809K $291K +$16K +5.82% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-14
Q2 2019 -$825K -$614K -$1.1M -228% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $270K -$116K +$482K +80.6% Feb 1, 2019 Apr 30, 2019 10-K 2020-07-28
Q4 2018 -$212K -$370K -$303K -452% Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-16
Q3 2018 $91K $275K +$345K Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-16
Q2 2018 -$254K $481K +$1.1M May 1, 2018 Jul 31, 2018 10-Q 2019-09-16
Q1 2018 -$1.35M -$598K +$1.79M +75% Feb 1, 2018 Apr 30, 2018 10-K 2019-07-29
Q4 2017 -$3.15M -$67K +$1.33M +95.2% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-18
Q3 2017 -$4.48M -$70K +$423K +85.8% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-17
Q2 2017 -$4.91M -$619K +$1.9M +75.5% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 -$6.81M -$2.39M +$161K +6.31% Feb 1, 2017 Apr 30, 2017 10-K 2018-07-30
Q4 2016 -$6.97M -$1.4M +$972K +41% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-19
Q3 2016 -$7.94M -$493K +$2M +80.2% Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-15
Q2 2016 -$9.94M -$2.52M +$374K +12.9% May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q1 2016 -$10.3M -$2.55M -$129K -5.32% Feb 1, 2016 Apr 30, 2016 10-K 2017-07-28
Q4 2015 -$10.2M -$2.37M +$1.05M +30.6% Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-17
Q3 2015 -$11.2M -$2.49M +$1.17M +32% Aug 1, 2015 Oct 31, 2015 10-Q 2016-12-14
Q2 2015 -$12.4M -$2.9M +$832K +22.3% May 1, 2015 Jul 31, 2015 10-Q 2016-09-14
Q1 2015 -$13.2M -$2.42M -$39K -1.64% Feb 1, 2015 Apr 30, 2015 10-K 2016-07-29
Q4 2014 -$13.2M -$3.42M -$2.01M -143% Nov 1, 2014 Jan 31, 2015 10-Q 2016-03-16
Q3 2014 -$11.2M -$3.67M -$1.97M -116% Aug 1, 2014 Oct 31, 2014 10-Q 2015-12-15
Q2 2014 -$9.22M -$3.73M -$2.96M -387% May 1, 2014 Jul 31, 2014 10-Q 2015-09-11
Q1 2014 -$6.26M -$2.39M -$399K -20.1% Feb 1, 2014 Apr 30, 2014 10-K 2015-07-29
Q4 2013 -$5.86M -$1.41M -$688K -95.6% Nov 1, 2013 Jan 31, 2014 10-Q 2015-03-17
Q3 2013 -$5.17M -$1.7M +$215K +11.2% Aug 1, 2013 Oct 31, 2013 10-Q 2014-12-15
Q2 2013 -$5.39M -$766K +$833K +52.1% May 1, 2013 Jul 31, 2013 10-Q 2014-09-12
Q1 2013 -$6.22M -$1.99M +$623K +23.9% Feb 1, 2013 Apr 30, 2013 10-K 2014-07-28
Q4 2012 -$6.84M -$720K +$1.05M +59.4% Nov 1, 2012 Jan 31, 2013 10-Q 2014-03-14
Q3 2012 -$7.9M -$1.92M +$553K +22.4% Aug 1, 2012 Oct 31, 2012 10-Q 2013-12-13
Q2 2012 -$8.45M -$1.6M +$615K +27.8% May 1, 2012 Jul 31, 2012 10-Q 2013-09-13
Q1 2012 -$9.07M -$2.61M +$222K +7.84% Feb 1, 2012 Apr 30, 2012 10-K 2013-07-26
Q4 2011 -$9.29M -$1.77M -$987K -126% Nov 1, 2011 Jan 31, 2012 10-Q 2013-03-13
Q3 2011 -$8.3M -$2.47M -$1.45M -143% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-13
Q2 2011 -$6.85M -$2.21M -$1.61M -267% May 1, 2011 Jul 31, 2011 10-Q 2012-09-12
Q1 2011 -$5.24M -$2.83M Feb 1, 2011 Apr 30, 2011 10-K 2012-07-18
Q4 2010 -$786K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-14
Q3 2010 -$1.02M Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-14
Q2 2010 -$603K May 1, 2010 Jul 31, 2010 10-Q 2011-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.